HSDT
$0.42
Helius Medical Technologies
$.00
(.97%)
HSDT
Earnings Whisper ®
N/A
3rd Quarter September 2020
Consensus:  ($0.09)
Revenue:  $0.10 Mil
Tuesday
Nov 10
4:05 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when HSDT reports earnings?
Beat
Meet
Miss

Where is HSDT's stock price going from here?
Up
Flat
Down
Stock chart of HSDT
Analysts
Summary of analysts' recommendations for HSDT
Score
Grade
Pivots
Resistance
-
-
-

-

Support
-
-
-
Tweet
Growth
Description
Helius Medical Technologies Inc. is a specialty medical device company. It is focused on the development and regulatory approval of its non-invasive neurostimulation device called PoNS. The Company is nearing clinical trials for balance disorders in TBI patients and for the treatment of MS. Helius Medical Technologies, Inc. is based in Newtown, Pennsylvania.